Specialty Pharmaceuticals for Hyperlipidemia — Impact on Insurance Premiums-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Specialty Pharmaceuticals for Hyperlipidemia — Impact on Insurance Premiums

Published:2015-10-22 Issue:17 Volume:373 Page:1591-1593
ISSN:0028-4793
Container-title:New England Journal of Medicine
language:en
Short-container-title:N Engl J Med

Author:

Schulman Kevin A.¹,Balu Suresh¹,Reed Shelby D.¹

Affiliation:

1. From the Duke Clinical Research Institute (K.A.S., S.D.R.) and the Duke Institute for Health Innovation (S.B.), Duke Translational Medicine Institute, and the Department of Medicine (K.A.S., S.D.R.), Duke University School of Medicine, Durham, NC.

Publisher

Massachusetts Medical Society

Subject

General Medicine

Link

http://www.nejm.org/doi/pdf/10.1056/NEJMp1509863

Cited by 25 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Performance-Based Risk-Sharing Arrangements (PBRSA): Is it a Solution to Increase Bang for the Buck for Pharmaceutical Reimbursement Strategy for Our Nation and Around the World?;Clinical Drug Investigation;2020-10-09

2. Aligning Delivery System and Training Missions in Academic Medical Centers to Promote High-Value Care;Academic Medicine;2019-09

3. Accuracy of budget impact estimations and impact on patient access: a hepatitis C case study;The European Journal of Health Economics;2019-04-05

4. Eligibility, Clinical Outcomes, and Budget Impact of PCSK9 Inhibitor Adoption: The CANHEART PCSK9 Study;Journal of the American Heart Association;2018-11-06

5. Emerging Trends in Clinical Research With Implications for Population Health and Health Policy;The Milbank Quarterly;2018-06

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP